(Q40763839)

23 September 2017

The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells (English)

1 reference

23 September 2017

Andrew J Skildum

1

1 reference

23 September 2017

Shibani Mukherjee

series ordinal

2

1 reference

23 September 2017

Susan E Conrad

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

7 December 2001

1 reference

Journal of Biological Chemistry

23 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 September 2017

277

1 reference

23 September 2017

5145-5152

1 reference

23 September 2017

7

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

23 September 2017

1 reference

Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Cell-cycle inhibitors: three families united by a common cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

The Cell Cycle Inhibitor p21CIPIs Phosphorylated by Cyclin A-CDK2 Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

The Protein SET Regulates the Inhibitory Effect of p21Cip1on Cyclin E-Cyclin-dependent Kinase 2 Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109179200

21 January 2018

Identifiers

DOI

10.1074/JBC.M109179200

1 reference

23 September 2017

1 reference